{"DataElement":{"publicId":"5633739","version":"1","preferredName":"Patient Neoplasm Clinical Trial Eligibility Criteria Type","preferredDefinition":"Tumor characteristics which are necessary to allow a subject to participate in a clinical study, as outlined in the study protocol.","longName":"PT_TUMOR_CRITERIA","context":"NRG","contextVersion":"1","DataElementConcept":{"publicId":"5633727","version":"1","preferredName":"Patient Neoplasm Clinical Trial Eligibility Criteria","preferredDefinition":"A person who receives medical attention, care, or treatment, or who is registered with medical professional or institution with the purpose to receive medical care when necessary._A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias._Characteristics which are necessary to allow a subject to participate in a clinical study, as outlined in the study protocol. The concept covers inclusion and exclusion criteria.","longName":"2233604v1.0:5633725v1.0","context":"NRG","contextVersion":"1","ObjectClass":{"publicId":"2233604","version":"1","preferredName":"Patient","preferredDefinition":"A person who requires medical care.","longName":"C16960","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Patient","conceptCode":"C16960","definition":"A person who receives medical attention, care, or treatment, or who is registered with medical professional or institution with the purpose to receive medical care when necessary.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F95D94B9-D847-2792-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-13","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-06-13","modifiedBy":"ONEDATA","dateModified":"2005-06-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"5633725","version":"1","preferredName":"Neoplasm Clinical Trial Eligibility Criteria","preferredDefinition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.:Characteristics which are necessary to allow a subject to participate in a clinical study, as outlined in the study protocol. The concept covers inclusion and exclusion criteria.","longName":"C3262:C16112","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Neoplasm","conceptCode":"C3262","definition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Clinical Trial Eligibility Criteria","conceptCode":"C16112","definition":"Characteristics which are necessary to allow a subject to participate in a clinical study, as outlined in the study protocol. The concept covers inclusion and exclusion criteria.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"46F1595D-1169-48FF-E053-F662850A9115","latestVersionIndicator":"Yes","beginDate":"2017-01-25","endDate":null,"createdBy":"GRANTD","dateCreated":"2017-01-25","modifiedBy":"ONEDATA","dateModified":"2017-01-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008525","version":"1","preferredName":"Eligibility","preferredDefinition":"trial-specific criteria that a patient must meet to be enrolled.","longName":"ELIG","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B1EC3968-9F25-305A-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-16","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-16","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"46F1595D-117A-48FF-E053-F662850A9115","latestVersionIndicator":"Yes","beginDate":"2017-01-25","endDate":null,"createdBy":"GRANTD","dateCreated":"2017-01-25","modifiedBy":"GRANTD","dateModified":"2017-01-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"5633734","version":"1","preferredName":"Patient Neoplasm Clinical Trial Eligibility CriteriaType","preferredDefinition":"Something distinguishable as an identifiable class based on common qualities.","longName":"5633734v1.0","context":"NRG","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"100","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Unresectable","valueDescription":"Unresectable","ValueMeaning":{"publicId":"2964842","version":"1","preferredName":"Unresectable","longName":"2964842","preferredDefinition":"Unable to be removed with surgery.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Unresectable","conceptCode":"C14151","definition":"Not capable of being removed by surgery.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7A02CEF7-C9D2-C96C-E040-BB89AD430150","latestVersionIndicator":"Yes","beginDate":"2009-12-05","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-12-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"46F1F0BC-D072-1315-E053-F662850A47BA","beginDate":"2017-01-25","endDate":null,"createdBy":"GRANTD","dateCreated":"2017-01-25","modifiedBy":"ONEDATA","dateModified":"2017-01-25","deletedIndicator":"No"},{"value":"Locally recurrent","valueDescription":"Locally Recurrent Disease","ValueMeaning":{"publicId":"5633735","version":"1","preferredName":"Locally Recurrent Disease","longName":"5633735","preferredDefinition":"To a restricted area (of the body).: The return of a disease after a period of remission.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Locally","conceptCode":"C41065","definition":"To a restricted area (of the body).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Recurrent Disease","conceptCode":"C38155","definition":"The return of a disease after a period of remission.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"46F1F0BC-D07C-1315-E053-F662850A47BA","latestVersionIndicator":"Yes","beginDate":"2017-01-25","endDate":null,"createdBy":"GRANTD","dateCreated":"2017-01-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"46F1F0BC-D095-1315-E053-F662850A47BA","beginDate":"2017-01-25","endDate":null,"createdBy":"GRANTD","dateCreated":"2017-01-25","modifiedBy":"ONEDATA","dateModified":"2017-01-25","deletedIndicator":"No"},{"value":"Radiographically proven","valueDescription":"Radiographic Examination Confirmation","ValueMeaning":{"publicId":"5633737","version":"1","preferredName":"Radiographic Examination Confirmation","longName":"5633737","preferredDefinition":"A radiographic procedure using the emission of penetrating energy waves to form an image of the structure penetrated by the radiation.: Having been established or verified.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Radiographic Examination","conceptCode":"C128940","definition":"A radiographic procedure using the emission of penetrating energy waves to form an image of the structure penetrated by the radiation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Confirmation","conceptCode":"C25458","definition":"Having been established or verified.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"46F1F0BC-D0A3-1315-E053-F662850A47BA","latestVersionIndicator":"Yes","beginDate":"2017-01-25","endDate":null,"createdBy":"GRANTD","dateCreated":"2017-01-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"46F1F0BC-D0BC-1315-E053-F662850A47BA","beginDate":"2017-01-25","endDate":null,"createdBy":"GRANTD","dateCreated":"2017-01-25","modifiedBy":"ONEDATA","dateModified":"2017-01-25","deletedIndicator":"No"},{"value":"Pathologically proven","valueDescription":"Pathologic Confirmation","ValueMeaning":{"publicId":"5633738","version":"1","preferredName":"Pathologic Confirmation","longName":"5633738","preferredDefinition":"Caused by or altered by or manifesting disease or pathology.: Having been established or verified.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pathologic","conceptCode":"C25610","definition":"Caused by or altered by or manifesting disease or pathology.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Confirmation","conceptCode":"C25458","definition":"Having been established or verified.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"46F1F0BC-D0C6-1315-E053-F662850A47BA","latestVersionIndicator":"Yes","beginDate":"2017-01-25","endDate":null,"createdBy":"GRANTD","dateCreated":"2017-01-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"46F1F0BC-D0DF-1315-E053-F662850A47BA","beginDate":"2017-01-25","endDate":null,"createdBy":"GRANTD","dateCreated":"2017-01-25","modifiedBy":"ONEDATA","dateModified":"2017-01-25","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008525","version":"1","preferredName":"Eligibility","preferredDefinition":"trial-specific criteria that a patient must meet to be enrolled.","longName":"ELIG","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B1EC3968-9F25-305A-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-16","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-16","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2234813","version":"1","preferredName":"Type","preferredDefinition":"Type; a subdivision of a particular kind of thing.","longName":"C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"F970CDF6-F90E-21D3-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-14","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-06-14","modifiedBy":"SBR","dateModified":"2005-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"46F1F0BC-D05D-1315-E053-F662850A47BA","latestVersionIndicator":"Yes","beginDate":"2017-01-25","endDate":null,"createdBy":"GRANTD","dateCreated":"2017-01-25","modifiedBy":"GRANTD","dateModified":"2017-01-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"Tumor criteria","type":"Preferred Question Text","description":"Tumor criteria","url":null,"context":"NRG"},{"name":"CRF Text_1","type":"Alternate Question Text","description":"Tumor Assessment","url":null,"context":"NRG"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"46F224AD-772B-2C9D-E053-F662850ABBCB","latestVersionIndicator":"Yes","beginDate":"2017-01-25","endDate":null,"createdBy":"GRANTD","dateCreated":"2017-01-25","modifiedBy":"BERGANTW","dateModified":"2017-01-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}